🇺🇸 FDA

Intelligence Platform

Patents

Browse 4 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12018074

Anti CCL24 (eotaxin2) antibodies for use in the treatment of hepatic diseases

CHEMOMAB LTD. · Granted Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11365246

Anti CCL24 (EOTAXIN2) antibodies for use in the treatment of hepatic diseases

CHEMOMAB LTD. · Granted Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10479830

Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines

CHEMOMAB LTD. · Granted Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10246508

Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines

CHEMOMAB LTD. · Granted Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted